[Federal Register Volume 86, Number 162 (Wednesday, August 25, 2021)]
[Notices]
[Page 47522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18230]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-860]


Bulk Manufacturer of Controlled Substances Application: Absolute 
Standards, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Absolute Standards, Inc., has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before October 25, 
2021. Such persons may also file a written request for a hearing on the 
application on or before October 25, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on May 31, 2021, Absolute Standards, Inc., 44 Rossotto 
Drive, Hamden, Connecticut 06514-1335, applied to be registered as a 
bulk manufacturer of the following basic class(es) of controlled 
substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Pentobarbital...........................    2270  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for internal use and for sale to its customers. No other 
activities for these drug codes are authorized for this registration.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-18230 Filed 8-24-21; 8:45 am]
BILLING CODE P